Hypoxic preconditioning reduces NLRP3 inflammasome expression and protects against cerebral ischemia/reperfusion injury

• Main Authors: Yi-Qiang Pang, Jing Yang, Chun-Mei Jia, Rui Zhang, Qi Pang
• Format: Article
• Language: English
• Published: Wolters Kluwer Medknow Publications 2022-01-01
• Series: Neural Regeneration Research
• Subjects: apoptosis; caspase-1; cell death; cerebral ischemia/reperfusion injury; gasdermin d; hippocampus; hypoxic preconditioning; nlrp3 inflammasome
• Online Access: http://www.nrronline.org/article.asp?issn=1673-5374;year=2022;volume=17;issue=2;spage=395;epage=400;aulast=Pang

Hypoxic preconditioning can protect against cerebral ischemia/reperfusion injury. However, the underlying mechanisms that mediate this effect are not completely clear. In this study, mice were pretreated with continuous, intermittent hypoxic preconditioning; 1 hour later, cerebral ischemia/reperfusion models were generated by middle cerebral artery occlusion and reperfusion. Compared with control mice, mice with cerebral ischemia/reperfusion injury showed increased Bederson neurological function scores, significantly increased cerebral infarction volume, obvious pathological damage to the hippocampus, significantly increased apoptosis; upregulated interleukin-1β, interleukin-6, and interleukin-8 levels in brain tissue; and increased expression levels of NOD-like receptor family pyrin domain containing 3 (NLRP3), NLRP inflammasome-related protein caspase-1, and gasdermin D. However, hypoxic preconditioning significantly inhibited the above phenomena. Taken together, these data suggest that hypoxic preconditioning mitigates cerebral ischemia/reperfusion injury in mice by reducing NLRP3 inflammasome expression. This study was approved by the Medical Ethics Committee of the Fourth Hospital of Baotou, China (approval No. DWLL2019001) in November 2019.